An excerpt from the BioVox White paper on Cancer Immunotherapy.
June 12, 2017 · BioVoxGrail has vowed to change the field of cancer diagnostics via simple blood tests and ctDNA analysis. Their Big Data approach, in which the company will build an atlas of DNA found in the blood, convinced major investors, such as Bill Gates and Jeff Bezos, of the technology’s potential. A whopping $1 billion was gathered in the company’s series B financing round. Yet, do Grail and its technology deserve this huge ticket?
March 15, 2017 · V-Bio VenturesThe University Hospital Center in Liège is expanding. The new comprehensive cancer center will be ready in 2018. The center focuses on high quality integrated care, and a large part of the building will be dedicated to outpatients in consultation and day-care without overnight hospitalization. The center will offer multidisciplinary care, focused on the overall wellbeing of the patient.
April 30, 2015 · Turnstone Communications